Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Challenges in the Diagnosis of EBV Encephalitis vs CNS CLL: A Case Report
Autoimmune Neurology
P4 - Poster Session 4 (8:00 AM-9:00 AM)
6-024
Chronic lymphocytic lymphoma (CLL) rarely presents with CNS involvement. EBV encephalitis is a difficult diagnosis based on diverse clinical manifestations most commonly presenting with altered mental status, and parkinsonism. Radiographic findings can include basal ganglia (BG) lesions. 

To present challenges in recognizing central nervous system (CNS) lymphoma involvement vs reactivation of Epstein Barr virus (EBV) infection in immunocompromised patients.

A case report is presented on a patient who presented to a tertiary care center in 2022. 

A 77-year-old male presented with cognitive decline and unsteady gait over 5 weeks. Medical history was significant for CLL genetic mutation variant (treatment naive) and essential tremor. Neurological examination was significant for severe cognitive decline with a Montreal Cognitive Assessment (MoCA ©) score of 13/30 and parkinsonism features. Brain MRI with and without gadolinium (Gd) contrast revealed no acute intracranial abnormality and routine electroencephalogram (EEG) with no electrographic seizures. Cerebrospinal fluid (CSF) analysis revealed pleocytosis WBC 30 with protein 107. Flow cytometry in CSF revealed monoclonal CD5+, CD23-, EBV+ B-cells consistent with a lymphoproliferative disorder (i.e. lymphoma, leukemia). Management included high-dose intravenous methylprednisolone (IVMP) for 5 days with an improved MoCA©score of 23/30 and resolution of cog-wheel rigidity.  
EBV encephalitis can involve the BG and present with reversible parkinsonism, commonly presenting as rhombencephalitis Discrepancies in CSF with monocytic predominance compared to monoclonal B cells and rapid response to steroids may be observed. This scenario represents challenges in the treatment approach for clinicians. 
Authors/Disclosures
Maria A. Garcia-Dominguez, MD (UMass Memorial Medical Center)
PRESENTER
Dr. Garcia-Dominguez has nothing to disclose.
Margaret A. Owegi, DO (University of Massachusetts Medical Center) No disclosure on file
Wissam G. Deeb, MD (UMass Memorial) Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to AAN interests or activities.
David Cachia, MD Dr. Cachia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for RedHill Biopharma Ltd. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GuidePoint Global LLC. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dedham Group. Dr. Cachia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Massachusetts Neurological Society.
Carolina Ionete, MD (UMass Memorial) Dr. Ionete has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from Biogen. The institution of Dr. Ionete has received research support from NIH.